Over 20 lakh healthcare workers across the country have received COVID-19 vaccine jabs till Tuesday evening, as per provisional reports, the Union Health Ministry said on Tuesday.
The Ministry said that on the 11th day of the nationwide immunisation drive, 5,615 beneficiaries were vaccinated till 7 p.m. in five States -- Tamil Nadu (4926), Karnataka (429), Rajasthan (216), Telangana (35) and Andhra Pradesh (9) -- through 194 sessions.
"The cumulative number of healthcare workers vaccinated against COVID-19 has crossed 20.29 lakh today. A total of 20,29,424 beneficiaries (till 7 pm today) have been vaccinated through 36,572 sessions, as per the provisional report," the Ministry said in a statement.
It said in view of Republic Day, a limited number of sessions in a limited number of states were conducted on Tuesday.
According to Health Ministry data, the highest number of vaccinations in the country till now have been carried out in Karnataka at 2,31,601 followed by Odisha at 1,77,090, Rajasthan at 1,61,332 and Maharashtra at 1,36,901.
You can track coronavirus cases, deaths and testing rates at the national and State levels here . A list of State Helpline numbers is available as well.
Here are live updates:
India records 9,102 fresh COVID-19 cases, 117 fatalities in a day
India reported 9,102 fresh coronavirus cases in a day, the lowest in around eight months, as the infection tally reached 1,06,76,838, according to Union Health Ministry data on Tuesday.
During the same period, 117 fatalities were recorded, also the lowest in over eight months, taking the death toll to 1,53,587.
India had reported a single-day rise of 8,909 cases on June 3 and 103 deaths on May 16.
According to the health ministry, 1,03,45,985 people have recuperated from the disease so far pushing the national COVID-19 recovery rate to 96.90%. The case fatality rate stood at 1.44%. - PTI
Tata likely to launch Moderna vaccine in India, says report
Tata Medical & Diagnostics is said to have started initial discussions with Moderna Inc. for a partnership to launch its COVID-19 vaccine in India, the Economic Times reported on Monday.
Tata could team up with the Council of Scientific & Industrial Research (CSIR) to carry out clinical trials of Moderna’s vaccine candidate in India, the report added, citing officials familiar with the matter.
Revised trial protocol sought on nasal vaccine for COVID-19
The clinical trial of Bharat Biotech’s intranasal vaccine for COVID-19 is likely to take some time to get off ground with a subject expert committee of the Central Drugs Standard Control Organisation (CDSCO) directing the vaccine maker to submit a revised trial protocol.
On an application from Bharat Biotech, seeking permission for phase I/II clinical trial of the Chimpanzee Adenovirus Vectored COVID-19 intranasal vaccine (BBV154), the committee said the firm should generate safety and immunogenicity data in Phase-I clinical trial, with 75 subjects, in the proposed doses as per the protocol.
